Üretral Darlıkların Endoskopik Yönetimi

Alrabadi A, Al Demour S, Mansi H, AlHamss S, Al Omari L. Evaluation of Voiding Position on Uroflowmetry Parameters and Post Void Residual Urine in Patients With Benign Prostatic Hyperplasia and Healthy Men. Am J Mens Health 2020;14(4). doi:10.1177/1557988320938969.

Sorel MR, Reitsma HJB, Rosier PFWM, Bosch RJLHR, de Kort LMO. Uroflowmetry in healt- hy women: A systematic review. Neurourol Urodyn 2017;36(4):953-959.

Lambert E, Denys MA, Poelaert F, Everaert K, Lumen N. Validated uroflowmetry-based predictive model for the primary diagnosis of urethral stricture disease in men. Int J Urol 2018;25(9):792-798.

Durham AE. On Internal Urethrotomy by Aid of a New Urethrotome. Br Med J 1878;1(898):358-360.

Konnak JW, Kogan BA. Otis internal urethrotomy in the treatment of urethral stricture dise- ase. J Urol 1980;124(3):356-357.

Horiguchi A, Shinchi M, Hirano Y, Asanuma H, Ishiura Y, Inoue K, vd. Clinical questions in the Japanese Urological Association’s 2024 clinical practice guidelines for urethral strictures. Int J Urol 2024;31(9):956-967.

FDA approves the Optilume® urethral drug coated balloon for the treatment of urethral stri- ctures. BJU Int 2022;129(3):305.

Elliott SP, Coutinho K, Robertson KJ, D’Anna R, Chevli K, Carrier S, vd. One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume® Drug-Coated Balloon for Anterior Urethral Strictures. J Urol 2022;207(4):866-874.

DeLong J, Virasoro R, Pichardo M, Estrella R, Rodríguez Lay R, Espino G, vd. Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Co- ated Balloon: Five-Year Results From the ROBUST I Study. J Urol 2025;213(1). doi:10.1097/ JU.0000000000004229.

VanDyke M, Joshi E, Ceballos B, Baumgarten A, Matz E, Graham KS, vd. Efficacy of the Optilume paclitaxel drug-coated balloon after urethroplasty: short-term results from a multi- center study. Ther Adv Urol 2025;17. doi:10.1177/17562872241312522.

Estaphanous P, Khalifa AO, Makar Y. Efficacy and Safety of Optilume Drug-Coated Bal loon for Urethral Stricture Treatment: A Systematic Review and Meta-Analysis. Cureus 2024;16(11). doi:10.7759/CUREUS.74069.

Dimitropoulos K, Greenwell T, Martins FE, Osman N, Ploumidis A, Riechardt S, vd. Urethral Strictures EAU Guidelines on.; 2024.

Oesterling JE. Urologic applications of a permanent, epithelializing urethral endoprosthesis. Urology 1993;41(1 Suppl):10-18.

Soni BM, Vaidyanatham S, Krishnan KR. Use of Memokath, a second generation urethral stent for relief of urinary retention in male spinal cord injured patients. Paraplegia 1994;32(7):480- 488.

Badlani GH. Role of permanent stents. J Endourol 1997;11(6):473-475.

Abdallah MM, Selim M, Abdelbakey T. Thermo-expandable metallic urethral stents for ma- naging recurrent bulbar urethral strictures: To use or not? Arab J Urol 2013;11(1):85-90.

Wong E, Tse V, Wong J. Durability of MemokathTM urethral stent for stabilisation of recurrent bulbar urethral strictures -- medium-term results. BJU Int 2014;113 Suppl 2(SUPPL. 2):35-39.

Buksh O, Jar A, Khogeer A, Alzahrani H, Akram R, Taher M, vd. Thermoexpandable Memo- kath stent: Usage and efficacy in ureteral and urethral strictures in Saudi Arabia. Urol Ann 2024;16(1):98-103.

Soliman C, Pan HYC, Mulholland CJ, Furrer MA, Agarwal DK, Lawrentschuk N, vd. Effect of local steroids on urethral strictures: A systematic review and meta-analysis. Investig Clin Urol 2022;63(3):273-284.

Tabassi KT, Yarmohamadi A, Mohammadi S. Triamcinolone Injection Following Internal Urethrotomy for Treatment of Urethral Stricture.; 2011. Available at: www.uj.unrc.ir.

Mazdak H, Izadpanahi MH, Ghalamkari A, Kabiri M, Khorrami MH, Nouri-Mahdavi K, vd. Internal urethrotomy and intraurethral submucosal injection of triamcinolone in short bulbar urethral strictures. Int Urol Nephrol 2010;42(3):565-568.

Hosseini J, Kaviani A, Golshan AR. Clean Intermittent Catheterization With Triamcinolone Ointment Following Internal Urethrotomy.; 2008. Available at: www.uj.unrc.ir.

Gücük A, Tuygun C, Burgu B, Öztürk U, Dede O, Imamoǧlu A. The short-term efficacy of dilatation therapy combined with steroid after internal urethrotomy in the management of urethral stenoses. J Endourol 2010;24(6):1017-1021.

Yesil S, Dede O, Dede G, Nalbant I, Zengin K, Abdurrahim Imamoglu M. The long-term effect of üretral dilatation therapy combined with steroid after internal urethrotomy. Gazi Medical Journal 2013;24(3). doi:10.12996/gmj.2013.24.

Ergün O, Güzel A, Armağan A, Koşar A, Ergün AG. A prospective, randomized trial to eva- luate the efficacy of clean intermittent catheterization versus triamcinolone ointment and contractubex ointment of catheter following internal urethrotomy: long-term results. Int Urol Nephrol 2015;47(6):909-913.

Regmi S, Adhikari SC, Yadav S, Singh RR, Bastakoti R. Efficacy of Use of Triamcinolone Ointment for Clean Intermittent Self Catheterization following Internal Urethrotomy. JNMA J Nepal Med Assoc 2018;56(212):745-748.

Xu C, Zhu Z, Lin L, Lv T, Cai T, Lin J. Efficacy of Mitomycin C Combined with Direct Vision Internal Urethrotomy for Urethral Strictures: A Systematic Review and Meta-Analysis. Urol Int 2023;107(4):344-357.

Rezaei M, Badiei R, Badiei R. The effect of platelet-rich plasma injection on post-internal urethrotomy stricture recurrence. World J Urol 2019;37(9):1959-1964.

Aydin A, Sonmez MG, Oltulu P, Kocabaş R, Sonmez LÖ, Taşkapu HH, vd. Is there a Diffe- rence in Platelet-Rich Plasma Application Method and Frequency to Protect Against Urethral Stricture? Urol J 2020;18(6):663-669.